Haddad FS, Ngu A, Negus JJ. Prosthetic Joint Infections and Cost Analysis? In: Springer, Cham; 2017. pp. 93–100. doi:10.1007/5584_2016_155.
Matsen Ko L, Parvizi J. Diagnosis of periprosthetic infection: novel developments. Orthop Clin N Am. 2016;47:1–9. doi:10.1055/s-0034-1371768.
Tissingh EK, Sudlow A, Jones A, Nolan JF. Orthopaedic surgical site infection surveillance in NHS England. Bone Joint J; 2017. p. 99. -B(2):171-174. doi:10.1302/0301-620X.99B2.BJJ-2016-0420.R1.
Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Jt Surg - Am Vol. 2014;96(4):272–278. doi:10.2106/JBJS.L.01268.
Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Jt Surg. 2003;85(4):484–489. doi:10.1302/0301-620X.85B4.13615.
Newman ET, Watters TS, Lewis JS. et al. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Jt Surg Am. 2014;96(4):279–284. doi:10.2106/JBJS.L.01041.
Maempel JF, Wickramasinghe NR, Clement ND, Brenkel IJ, Walmsley PJ. The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplasty. Bone Jt J. 2016;98B(4):490–497. doi:10.1302/0301-620X.98B4.36245.
Padegimas EM, Clyde CT, Zmistowski BM, Restrepo C, Williams GR, Namdari S. Risk factors for blood transfusion after shoulder arthroplasty. Bone Joint J; 2016. p. 98. -B(2):224-228. doi:10.1302/0301-620X.98B2.36068.
Weber EW, Slappendel R, Prins MH, Van Der Schaaf DB, Durieux ME, Strümper D. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: Effects on duration of hospitalization. Anesth Analg. 2005;100(5):1416–1421. doi:10.1213/01.ANE.0000150610.44631.9D.
Kim JL, Park J-H, Han S-B, Cho IY, Jang K-M. Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis. J Arthroplasty. 2017;32(1):320–325. doi:10.1016/j.arth.2016.08.026.
Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood Transfusion in Primary Total Hip and Knee Arthroplasty. Incidence, Risk Factors, and Thirty-Day Complication Rates. J Bone Jt Surg. 2014;96(23):1945–1951. doi:10.2106/JBJS.N.00077.
Rusk A, Bush K, Brandt M. et al. Improving Surveillance for Surgical Site Infections Following Total Hip and Knee Arthroplasty Using Diagnosis and Procedure Codes in a Provincial Surveillance Network. Infect Control Hosp Epidemiol. 2016;37(6):699–703. doi:10.1017/ice.2016.53.
Marshall DA, Christiansen T, Smith C. et al. Continuous quality improvement program for hip and knee replacement. Am J Med Qual. 2015;30(5):425–431. doi:10.1177/1062860614540512.
Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med. 1991;10(8):1213–1226. doi:10.1002/sim.4780100805.
Frisch NB, Wessell NM, Charters MA, Yu S, Jeffries JJ, Silverton CD. Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty. 2014;29(9 SUPPL.):189–192. doi:10.1016/j.arth.2014.03.048.
Vallion R, Bonnefoy F, Daoui A. et al. Transforming growth factor-B released by apoptotic white blood cells during red blood cell storage promotes transfusion-induced alloimmunomodulation. Transfusion. 2015;55(7):1721–1735. doi:10.1111/trf.13031.
Hebert PC, Yetisir E, Martin C. et al. Is a low transfusion threshold safe in critically ill patient with cardiovascular diseases? Crit Care Med. 2001;29(2):227–234. doi:10.1097/00003246-200109001-00007.